All In Biotech

Drug Trial Radar · NCT00013520

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Phase III, Randomized, Double-Blind Comparison of Three Protease Inhibitor-Sparing Regimens for the Initial Treatment of HIV Infection

Last checked: Nov 19, 2026Latest source record: May 21, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,125

Actual

Start

Not stated

Primary completion

Not stated

Study completion Jun 2005

Sponsor

Sponsor type
NIH
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the effectiveness, safety, and tolerability of 3 anti-HIV combination treatments that do not use protease inhibitors (PIs). The current rule for starting treatment of HIV infection is to combine members from different classes of anti-HIV drugs, such as 2 nucleoside reverse transcriptase inhibitors (NRTIs) and either a PI or a nonnucleoside reverse transcriptase inhibitor (NNRTI). However, these combinations can be complicated and difficult to take, can cause a number of side effects, and may become ineffective. Combinations that are simpler, better tolerated, and more effective are needed. Because PIs can cause long-term side effects and because HIV can become resistant to many of them at the same time, anti-HIV combination treatments that do not use PIs are being tested.

Conditions

  • HIV Infections

Interventions

  • Abacavir sulfate, Lamivudine and ZidovudineDrug

  • AtazanavirDrug

  • Lamivudine/ZidovudineDrug

  • Abacavir sulfateDrug

  • EfavirenzDrug

  • NevirapineDrug

  • LamivudineDrug

  • StavudineDrug

  • ZidovudineDrug

  • DidanosineDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

60 sites in 2 countries. Site status is shown where the registry gives one.

  • Alabama Therapeutics CRS

    Birmingham, Alabama

  • USC CRS

    Los Angeles, California

  • UCLA CARE Center CRS

    Los Angeles, California

  • Stanford CRS

    Palo Alto, California

  • UC Davis Medical Center

    Sacramento, California

  • Univ. of California Davis Med. Ctr., ACTU

    Sacramento, California

  • Ucsd, Avrc Crs

    San Diego, California

  • Ucsf Aids Crs

    San Francisco, California

  • Santa Clara Valley Med. Ctr.

    San Jose, California

  • San Mateo County AIDS Program

    San Mateo, California

  • Willow Clinic A0507 CRS

    San Mateo, California

  • Harbor-UCLA Med. Ctr. CRS

    Torrance, California

  • University of Colorado Hospital CRS

    Aurora, Colorado

  • Georgetown University CRS (GU CRS)

    Washington D.C., District of Columbia

  • Univ. of Miami AIDS CRS

    Miami, Florida

  • The Ponce de Leon Ctr. CRS

    Atlanta, Georgia

  • Univ. of Hawaii at Manoa, Leahi Hosp.

    Honolulu, Hawaii

  • Northwestern University CRS

    Chicago, Illinois

  • Rush Univ. Med. Ctr. ACTG CRS

    Chicago, Illinois

  • Cook County Hosp. CORE Ctr.

    Chicago, Illinois

  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic

    Indianapolis, Indiana

  • Indiana Univ. School of Medicine, Wishard Memorial

    Indianapolis, Indiana

  • Methodist Hosp. of Indiana

    Indianapolis, Indiana

  • Univ. of Iowa Healthcare, Div. of Infectious Diseases

    Iowa City, Iowa

  • Johns Hopkins Adult AIDS CRS

    Baltimore, Maryland

  • Massachusetts General Hospital ACTG CRS

    Boston, Massachusetts

  • Bmc Actg Crs

    Boston, Massachusetts

  • Beth Israel Deaconess Med. Ctr., ACTG CRS

    Boston, Massachusetts

  • Brigham and Women's Hosp. ACTG CRS

    Boston, Massachusetts

  • SSTAR, Family Healthcare Ctr.

    Fall River, Massachusetts

  • University of Minnesota, ACTU

    Minneapolis, Minnesota

  • St. Louis ConnectCare, Infectious Diseases Clinic

    St Louis, Missouri

  • Washington U CRS

    St Louis, Missouri

  • Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr.

    Omaha, Nebraska

  • SUNY - Buffalo, Erie County Medical Ctr.

    Buffalo, New York

  • Beth Israel Med. Ctr., ACTU

    New York, New York

  • Weill Med. College of Cornell Univ., The Cornell CTU

    New York, New York

  • NY Univ. HIV/AIDS CRS

    New York, New York

  • Cornell CRS

    New York, New York

  • Columbia Univ., HIV Prevention and Treatment Medical Ctr.

    New York, New York

Showing 40 of 60 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.